Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 345 Records) |
| Query Trace: Disease and CYP2C19[original query] |
|---|
| CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and translational science 2023 8 . Markus Ramste, Markus Ritvos, Sergei Häyrynen, Johanna I Kiiski, Mikko Niemi, Juha Sinisa |
| Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients. International journal of general medicine 2023 8 16 3473-3481. Yuliang Shi, Yuxian Yang, Miaoling Feng, Weihan Ling, Tongguo Wei, Yumin Cao, Rui Zhong, Heming |
| A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps. Pharmacogenomics and personalized medicine 2023 6 16 645-664. Eda Eken, David S Estores, Emily J Cicali, Kristin K Wiisanen, Julie A Johns |
| VARIANTS OF THE FORMATION AND COURSE OF DRUG-RESISTANT EPILEPSY IN CHILDREN WITH GENETIC POLYMORPHISMS OF CYP2C9, CYP2C19, CYP3A4. Wiadomosci lekarskie (Warsaw, Poland : 1960) 2023 6 76 (5 pt 1): 1007-1013. Liudmyla M Tantsura, Olena Yu Pylypets, Dmytro V Tretiakov, Yevhen O Tantsu |
| PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes. Archives of pharmacal research 2023 12 . Chang-Keun Cho, Eunvin Ko, Ju Yeon Mo, Pureum Kang, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong Lee, Jung-Woo Bae, Chang-Ik Ch |
| Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. Journal of atherosclerosis and thrombosis 2023 12 . Wei-Ting Chang, Po-Sen Huang, Li-Wei Su, Chia-Te Liao, Han Siong Toh, Yi-Chen Chen, Chung-Han Ho, Zhih-Cherng Chen, Po-Chao Hsu, Chon-Seng Ho |
| Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance. JPMA. The Journal of the Pakistan Medical Association 2023 12 73 (12): 2388-2392. Usman Nawaz, Mudassar Noor, Akbar Wahe |
| The combination of CYP2C19 polymorphism and inflammatory cell ratios in prognosis cardiac adverse events after acute coronary syndrome. International journal of cardiology. Cardiovascular risk and prevention 2023 11 19 200222. Toan Hoang Ngo, Nha Tran Khuong Nguyen, Nga Thi Ngoc Pham, Bao Lam Thai Tran, An Tuan Huynh, Khue Duy Nguyen, Khuong Duy Nguyen, An Viet Tr |
| Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians. The journal of gene medicine 2023 11 e3634. Keshavamurthy Ganapathy Bhat, Ratheesh Kumar Janardhana Pillai, Heemanshu Lodhi, Vivek Singh Guleria, Anil Kumar Abbot, Love Gupta, Garima Rastogi, Anuka Sharma, Zafar Mohammed, Varun Shar |
| CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program. medRxiv : the preprint server for health sciences 2023 11 . Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, Kyung Min Lee, Zhenyu Lu, Julie A Lynch, Scott L DuVall, Jason L Vassy, Stephen W Waldo, John H Cleator, Thomas M Maddox, Daniel J Rader, Themistocles L Assimes, Scott M Damrauer, Philip S Tsao, Kyong-Mi Chang, Deepak Voora, Jay Giri, Sony Tute |
| Role of genetic polymorphisms in clopidogrel response variability: a systematic review. Open heart 2023 11 10 (2): . Jose Lopez, Justin Mark, Gustavo J Duarte, Mohammed Shaban, Franklin Sosa, Rishabh Mishra, Swati Jain, An Tran, Asma Khizar, Daniel Karpel, Giancarlo Acosta, Miguel Rodriguez-Guer |
| Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics. Therapeutic advances in rare disease 2023 11 4 26330040231204643. Stephanie Feleus, Maaike van der Lee, Jesse J Swen, Raymund A C Roos, Susanne T de B |
| CYP2C19 Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel. JACC. Advances 2023 10 2 (7): None. Emma F Magavern, Benjamin Jacobs, Helen Warren, Gherardo Finocchiaro, Sarah Finer, David A van Heel, , Damian Smedley, Mark J Caulfie |
| Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. Drugs 2024 9 . Dominique P M S M Maas, Loes H Willems, Josephine Kranendonk, Cornelis Kramers, Michiel C War |
| [Relationship between clopidogrel resistance and genetic variability in Kawasaki disease children with coronary artery lesions]. Zhonghua er ke za zhi = Chinese journal of pediatrics 2024 9 62 (10): 981-988. Y Y Cao, Q Y Pan, J Li, X F Zhong, X C Liang, L He, C Chu, Q M Zhao, L Zhao, F Wang, S N Sun, Y X Lin, G Y Huang, F L |
| Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach. International journal of cardiology 2024 8 414 132418. Ruchika Sharma, Geeta Aggarwal, Anoop Kumar, Ajit K Thakur, Mahak Pandit, Varun Sharma, Manmohan Singh, Jaseela Majeed, Puneeta Ajme |
| Can CYP2C19 genotyping improve antiplatelet therapy efficacy in real-life practice? Recent advances. Kardiologia polska 2024 8 . Udaya S Tantry, Sahib Singh, Lekshmi Narayan Raghavakurup, Kevin P Bliden, Paul A Gurb |
| Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction. Clinical pharmacology and therapeutics 2024 7 . Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Julio D Duarte, Yan Gong, Joseph S Rossi, Amber L Beitelshees, George A Stouffer, Craig R Lee, Dominick J Angiolillo, Larisa H Cavalla |
| Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease. Journal of the Canadian Association of Gastroenterology 2024 6 7 (3): 238-245. Cheng-Chun Tai, Samantha Medwid, Keith Mclntosh, Nilesh Chande, Richard B Kim, James Greg |
| Analysis of the effect of CYP2C19 gene properties on the anti-platelet aggregation of clopidogrel after carotid artery stenting under network pharmacology. BMC pharmacology & toxicology 2024 6 25 (1): 34. Pengfei Li, Mengying Cao, Ling Liu, Long Chen, Shuang Liang, Youbin Wa |
| CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association. Circulation 2024 6 . Naveen L Pereira, Sharon Cresci, Dominick J Angiolillo, Wayne Batchelor, Quinn Capers, Larisa H Cavallari, Dana Leifer, Jasmine A Luzum, Dan M Roden, Konstantinos Stellos, Stephanie L Turrise, Sony Tuteja, |
| Association of genetic variations of 3'-UTR in clopidogrel pharmacokinetic-relevant genes with clopidogrel response in Han Chinese patients with coronary artery disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2024 6 200 106830. Dongjie Li, Boyu Xiang, Jingxuan Peng, He Li, Liming Peng, Xiaoping Ch |
| Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting. Thrombosis research 2024 6 240 109060. Alba Antúnez-Rodríguez, Sonia García-Rodríguez, Ana Pozo-Agundo, Jesús Gabriel Sánchez-Ramos, Eduardo Moreno-Escobar, José Matías Triviño-Juárez, Luis Javier Martínez-González, Cristina Lucía Dávila-Fajar |
| Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 2024 4 25 (7): . Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio J Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander, Pablo Zubia |
| Effectiveness of Clopidogrel vs Alternative P2Y Inhibitors Based on the ABCD-GENE Score. Journal of the American College of Cardiology 2024 4 83 (15): 1370-1381. Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Luis Ortega-Paz, Yan Gong, Richard A Kerensky, Natasha Kulick, Caitrin W McDonough, Anh B Nguyen, Yehua Wang, Marshall Winget, William E Yang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Craig R Lee, Larisa H Cavalla |
| Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis. Pediatric pulmonology 2024 11 . Rebecca S Pettit, Coleen M Sakon, Kaitlyn E Kinney, Cynthia Brown, Katherine A Gallaway, Sarah A Wagner, Emma M Tillm |
| Drug-gene interactions in older patients with coronary artery disease. BMC geriatrics 2024 10 24 (1): 881. Shizhao Zhang, Chao Lv, Lisha Dong, Yangxun Wu, Tong Y |
| Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago. Cardiology and therapy 2024 1 . Daniele Jones, Shana Persad-Ramdeensingh, Sheherazade Crystal Abrahim, Naveen Seecheran, Rajini Rani Haraksin |
| A novel AllGlo probe-quantitative PCR method for detecting single nucleotide polymorphism in CYP2C19 to evaluate the antiplatelet activity of clopidogrel. Scientific reports 2024 1 14 (1): 2358. Hongwei Li, Yizhen Fang, Yongquan Chen, Yuning Lin, Zanxi Fang, Zhiyuan Lin, Huabin Xie, Zhongying Zha |
| CYP2C19 and CES1 gene variants affecting clopidogrel metabolism in a South Asian population from Sri Lanka. Pharmacogenomics 2025 1 1-4. Priyanga Ranasinghe, Pulasthi B Gunarathna, Hajanthy Jeyapragasam, Nirmala Sirisena, D P Bhagya Hendalage, Vajira H W Dissanaya |
- Page last reviewed:Feb 1, 2024
- Content source: